This inventor holds 3 USPTO granted patents. Top assignees: Merck Patent Gmbh, Emd Lexigen Research Center Corp.. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: The Innovative Mind of John S. Wesolowski, Jr.
Introduction
John S. Wesolowski, Jr. is a prominent inventor based in Weymouth, Massachusetts, known for his groundbreaking contributions to immunology and the development of fusion protein technologies. With a total of three patents, Wesolowski's work focuses on enhancing immunogenicity in protein and peptide antigens, paving the way for advancements in vaccines and therapeutic applications.
Latest Patents
Wesolowski's latest patents detail innovative methods for using Fc-cytokine fusion proteins. These inventions disclose methods and compositions aimed at enhancing the immunogenicity of preselected protein or peptide antigens in mammals. By fusing the antigens to an immunoglobulin heavy chain constant region, Wesolowski's Fc-antigen fusion proteins target specific Fc receptors on antigen-presenting cells, resulting in improved immune responses. Furthermore, the patents introduce a family of adjuvants, such as Fc-adjuvant fusion proteins, designed to work in conjunction with the Fc-antigen fusion proteins to modulate and enhance the immune response to targeted antigens.
Career Highlights
John S. Wesolowski, Jr. has made significant strides in the field of biotechnology throughout his career. He has worked with reputable companies such as Merck Patent GmbH and EMD Lexigen Research Center Corporation, where he has been instrumental in advancing research and development in vaccine technology and immunology.
Collaborations
Collaboration has been a key aspect of Wesolowski's career. He has notably worked alongside esteemed colleagues, including Stephen D. Gillies and Kin-Ming Lo. These collaborations have not only expanded his innovative thinking but have also contributed to the successful development of his patents.
Conclusion
John S. Wesolowski, Jr. stands out as a remarkable inventor whose contributions to immunogenicity and fusion protein technology are shaping the future of immunology. His patents serve as a testament to his commitment to innovation and the advancement of medical science, promising benefits for therapeutic and vaccine development in the years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile